Cryoport, Inc. Form 8-K Summary
Business Context and Reporting Period
Cryoport, Inc. (CYRX), a Nevada corporation, filed this Current Report on Form 8-K on November 10, 2021, covering events that occurred on November 9, 2021. The filing addresses significant capital raising activities executed by the Company.
Key Financial Metrics
This filing does not contain audited financial statements, revenue, profit, cash flow, or margin data. The primary financial event reported is the pricing of a new debt offering and an equity placement:
- Debt Offering: Pricing of 0.750% Convertible Senior Notes due 2026.
- Equity Offering: Pricing of a registered direct placement of common stock.
- Liquidity Impact: Specific proceeds amounts are not detailed in the text of this 8-K; they are referenced in attached press releases (Exhibits 99.1 and 99.2).
Material Changes
The material change reported is the execution of a dual capital raise strategy involving both convertible debt and common stock. This represents a significant alteration to the Company's capital structure compared to the prior period, though specific pre-transaction debt or equity balances are not provided in this document.
Guidance, Outlook, and Risks
The filing does not provide updated financial guidance, management commentary on future operations, or specific risk factors beyond the standard disclaimer that the report and attached press releases do not constitute an offer to sell securities. The transaction was conducted pursuant to Rule 144A under the Securities Act of 1933.
Investor Verification Checklist
- Verify the total aggregate principal amount of the 0.750% Convertible Senior Notes due 2026 in the attached press release (Exhibit 99.1).
- Confirm the number of shares and price per share for the registered direct placement of common stock in the attached press release (Exhibit 99.2).
- Review the conversion terms and maturity details of the new Notes to assess potential future dilution.
- Check the use of proceeds disclosed in the press releases to understand the strategic intent of the capital raise.